Precision medicine research at Karmanos comparing biomarker
By A Mystery Man Writer
Description
A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and
IJMS, Free Full-Text
Biomarkers and Precision Medicine in Oncology Practice and
PDF) TMB: a promising immune-response biomarker, and potential
Research Lange Lab
The Evolution Of Biomarker-driven Approaches To Clinical Trials
Identification of Differentially Secreted Biomarkers Using LC-MS
Making Biomarkers Relevant to Healthcare Innovation and Precision
Cancer screening event at Karmanos Cancer Institute to help Southeast Michigan get back on track
IN THE NEWS: Sk8 to Eliminate Cancer Ice Show Detroit 2022
Precision medicine: preliminary results from the Initiative for
Patient Stories
Karmanos Cancer Institute on LinkedIn: #yourbestchance #onepride
Planning begins for new digital resource and seminars to help cancer patients navigate financial barriers, thanks to MHEF grant
Cancers, Free Full-Text
Biomarker development in the precision medicine era: lung cancer
from
per adult (price varies by group size)